Literature DB >> 23844668

The genetics of Canadian type 3 von Willebrand disease: further evidence for codominant inheritance of mutant alleles: a reply to a rebuttal.

M Bowman1, D Lillicrap, P James.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23844668      PMCID： PMC3904640          DOI： 10.1111/jth.12348

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.

Authors:  F Rodeghiero; G Castaman; A Tosetto; J Batlle; F Baudo; A Cappelletti; P Casana; N De Bosch; J C J Eikenboom; A B Federici; S Lethagen; S Linari; A Srivastava
Journal:  J Thromb Haemost       Date:  2005-12       Impact factor: 5.824

2.  Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire.

Authors:  M Bowman; J Riddel; M L Rand; A Tosetto; M Silva; P D James
Journal:  J Thromb Haemost       Date:  2009-05-30       Impact factor: 5.824

3.  Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire.

Authors:  T T Biss; V S Blanchette; D S Clark; M Bowman; C D Wakefield; M Silva; D Lillicrap; P D James; M L Rand
Journal:  J Thromb Haemost       Date:  2010-02-02       Impact factor: 5.824

4.  Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease.

Authors:  M Bowman; G Mundell; J Grabell; W M Hopman; D Rapson; D Lillicrap; P James
Journal:  J Thromb Haemost       Date:  2008-10-04       Impact factor: 5.824
  4 in total
  2 in total

1.  von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells.

Authors:  Mackenzie Bowman; Lara Casey; Soundarya N Selvam; Patricia D A Lima; Orla Rawley; Megan Hinds; Angie Tuttle; Julie Grabell; Alfonso Iorio; Irwin Walker; David Lillicrap; Paula James
Journal:  J Thromb Haemost       Date:  2022-05-03       Impact factor: 16.036

2.  Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system.

Authors:  Yuto Nakajima; Keiji Nogami; Koji Yada; Takeshi Kawamura; Kenichi Ogiwara; Shoko Furukawa; Naruto Shimonishi; Masahiro Takeyama; Midori Shima
Journal:  Int J Hematol       Date:  2019-11-18       Impact factor: 2.490
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.